Monday, September 30, 2019

Global Electrical Conduit Pipe Market to Witness CAGR of ~5% Increase in Value Share During the Forecast Period 2019 and 2029


The global sales of electrical conduit pipes reached ~ 26,400 thousand tons in 2018, unveils the new research report on the electrical conduit pipe market by Persistence Market Research (PMR). According to the electrical conduit pipe market report, the electrical conduit pipe market is estimated to grow by ~ 5% CAGR in 2029, primarily influenced by the recent government investment on the smart grid project.

According to the report, increasing electricity consumption in the rural area is anticipated to drive demand for the electricity production, which is expected to positively drive the electrical conduit pipe market. Furthermore, increasing usage of modern electric appliances in rural areas will contribute to the build-up of the electrical conduit pipe market through to 2029. The global electrical conduit pipe market reflected a value of ~US$ 26 Bn in 2018, and is projected to reach a market valuation of ~US$ 43 Bn by the end of the 2029.


Plastic Electrical Conduit Pipe Captures Significant Share

Plastic has high anti-corrosion, light-weight, dialectical strength, and UV stabilization properties, thereby gaining high demand in the electrical conduit pipe market. Use of plastic as a raw material in electric conduit pipes is expected to be highly profitable, owing to its several credible properties and cost-effectiveness. On the other hand, metal is projected to have slow adoption as compared plastic during the forecast period.
As per the PMR study, prominent players in the electrical conduit pipe market are offering wide range of products with advanced characteristic properties, such as enhanced strength and stiffness. These properties serve applications such as commercial refrigeration, secondary cooling of food production, and central plant HVAC systems, among others.  Some of the products include steel reinforced polyethylene pipes and corrugated double wall pipes.
The demand for metal pipes is projected to rise over the forecast period as manufacturers are preferring environmental-friendly material type, which is more resistant to the external damage.


By application type, the IT & telecommunication sector of the electrical conduit pipe market is expected to be prominent in the global electrical conduit pipe market over the forecast period. Electrical conduit pipes function as a medium of transmission for telecommunication and electricity over long distances. Owing to several external factors such as salt concentration and oxygen concentration, conduit pipes are susceptible to corrosion over time. Therefore, the IT & telecommunication sector is estimated to grow at a CAGR of ~5% and projected to reach at ~US$ 17,000 Mn by the end of 2029.

Telecommunication Operations by Several End-use Industries in Asia Pacific is Expected to Create Growth Opportunities

The telecommunication industry is growing at a significant rate in the Asia Pacific region. Owing to the increasing utilization of conduit pipes to ensure safety of telecommunication wires, such as optical fiber cables under sea, and the growing telecommunication industry, are expected to directly impact the growth of the electrical conduit pipe market. These factors are significant drivers responsible for boosting the demand for electrical conduit pipes in the global market. According to the IBEF (India Brand Equity Foundation), India is estimated to be the world’s 2nd largest telecommunication market. This factor propels the demand for electrical conduit pipes for long distance cabling of telecommunication operations in the region. Several telecommunication companies are expanding their fiber cable network, which is anticipated to create a positive impact on the growth of the electrical conduit pipe market.


Electrical Conduit Pipe Market: Vendor Insights

PMR’s business analysis also highlights pioneering insights into the competitive scenario of the electrical conduit pipe market and differential strategies of prominent market players. Some key players in the market are JM Eagle, Inc., Aliaxis SA, Mexichem SAB de CV, and China Lesso Group Holdings Ltd., among others. Furthermore, several prominent players of the electrical conduit pipe market are adopting strategies, such as collaborations, joint ventures, and acquisitions to establish their distribution and sales network across the globe. For instance, in 2019, Aliaxis SA, manufacturer and distributor of advanced plastic piping systems, acquired Silver-Line Plastics, which is a U.S.-based plastic pipe products manufacturing company.

This study highlights key opportunities in the electrical conduit pipe market and discovers that the market would exhibit growth at a value CAGR of ~5% during the forecast period. 

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
at No comments:

Global Breast Implant Market to Witness CAGR of ~3% Increase in Value Share During the Forecast Period 2019 and 2029


Worldwide sales of breast implants is expected to reach ~ US$ 1.8 Bn by the end of 2019 and is forecasted to reach ~ US$ 1.7 Bn by the end of 2029, unveils the new research study by Persistence Market Research (PMR). According to the report, the breast implants market is estimated to grow by ~3% Y-O-Y by the end of 2020, primarily influenced by the recent advancements in the breast implants market.

According to the report, greater emphasis on physical appearance of the breasts and rise in global per capita disposable income of women have led to more number of women undergoing breast implants procedures globally. Also, manufacturers of breast implants are focusing on introducing wide range of breast implants in terms of sizes, shapes, and texture, which is expected to upsurge the growth of the global breast implants market over the forecast period.


Combined Breast Augmentation to Create Scope for the Market Growth

Breast augmentation procedures in combination with breast lifting have received much attention among women in recent years to enhance the appearance of their breasts in terms of shape and size particularly those who are concerned with deflated or sagging breast appearance. While a breast lift procedure will elevate and reshape breasts, breast implants will add volume to their breasts.

Also combined procedural cost is less when compared to the individual procedure leading to more number of women opting for both procedures at one time. These factors are anticipated to aid the growth of the breast implants market over the forecast period.

Strong Distribution Network to Drive the Breast Implants Market

Strong distribution network is one of the prime factors responsible for the growth of the global breast implants market. Various major implants manufacturers are undergoing distribution agreements in order to make their products available resulting in deep penetration of aesthetic services across low income countries. Thus, easier availability of products and increasing demand for breast implants products globally, is contributing to the overall growth of the breast implants market.

Greater Emphasis on Physical Appearance is a Factor Fueling the Market Growth

Greater emphasis on aesthetic appearance is the main factor fueling revenue growth of the breast implants market globally. A large number of women are conscious about the physical appearance of their breasts leading to increasing number of breast augmentation procedures in developed countries such as North America and Europe. However, some of the most common reasons for breast augmentation procedures include changing the breast size, restoring natural appearance of breasts, and correcting capsular contracture. 


Also, women are increasingly spending on cosmetic surgical procedures to enhance their physical appearance and the number is expected to rise significantly over the next few years.
According to the U.S.-based National Institute of Aging and American Academy of Plastic Surgeons, a significant share of the population in the U.S., primarily within the age group of 18-30 years and onwards, are increasingly resorting to advanced aesthetic services including breast implants thus, creating sufficient traction for manufacturers in the breast implants market.


 Composite Breast Augmentation to Boost Patient Base for Breast Implants

Composite breast augmentation combines the ability of a breast implants to provide increased volume of breasts with reshaping capabilities offered by fat grafting technique. The technology together provides more versatility, especially in women who are more concerned about animation deformities and patients who are athletic. The technique is expected to have a major influence on the breast implants market globally over the next few years.

This study underlines key opportunities in the breast implants market and finds that the market would exhibit growth at a value CAGR of ~3% during forecast period.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
at No comments:

Global Acoustic Emission Based Ndt Market to Witness CAGR of ~7% Increase in Value Share During the Forecast Period 2018 and 2028.



 Persistence Market Research released a new market research on the acoustic emission-based NDT market, which covers the global industry forecast 2018–2028 and analysis 2013–2017. The report explore the global acoustic emission-based NDT market and provides in-depth analysis for the coming years from 2018 to 2028. The report on the global acoustic emission-based NDT market includes forecast factors and vital macroeconomic that are anticipated to fuel the growth of the global acoustic emission-based NDT market. The report on the acoustic emission-based NDT market also addresses restraints that are projected to hinder the growth of the market, along with the latest trends and potential opportunities in the market.

The global acoustic emission-based NDT market was valued at ~ US$ 197 Mn in 2013, and is projected to generate a value of US$ 523 Mn by the end of 2019. The acoustic emission-based NDT market is anticipated to grow at a CAGR of ~ 7% between 2018 and 2028.


East Asia to Reach New Heights in Infrastructural Development

The development rate of countries in East Asia are increasing at a higher pace in social infrastructure. The importance of upgraded social infrastructure has been creating numerous opportunities for various industries. Hence, one of the significant global infrastructure projects “The Belt and Road Initiative (BRI)” that links China with rest of Asia, Europe, and Africa has the participation of more than 29 international organizations. The project involves the construction of roads, bridges, and railway networks, which is expected to surge the demand for acoustic emission-based NDT. The acoustic emission-based NDT holds its significance from the quality check of raw materials to monitoring of structures even when in use. With the completion of this global project, the region of East Asia is anticipated to develop new opportunities, boost Chinese income and product consumption, and cultivate export markets.

Request Methodology of this report @ https://www.persistencemarketresearch.com/methodology/23443 

The semiconductor manufacturing market players in these regions are estimated to invest in the development of piezoelectric devices with different range of frequencies for various applications. The trend of infrastructure outlook has developed key focus of companies in the acoustic emission-based NDT market.
Emerging Players in the Acoustic Emission-based NDT Market to Account for ~ 20% Revenue Share
The global acoustic emission-based NDT market is defined as moderately consolidated, owing to the presence of a limited number of top service providers of acoustic emission-based NDT across the globe. For in-depth analysis, Persistence Market Research has broken down the market structure up to three levels: Tier 1, Tier 2, and Tier 3. Here, emerging players are estimated to account for ~ 20% share in the global market and generate ~ US$ 40 Mn revenue through sales of acoustic emission-based NDT across the world. Moreover, leading players in the global acoustic emission-based NDT market are incorporating acquisitions, collaboration strategies, and adopting the business expansion in a bid to capture a significant share in the global market.

  • In December 2018, MISTRAS acquired Novacap-backed onstream pipeline inspection services. The competitive advantages of onstream and its strong presence in the inline inspection provides a stout foundation within the midstream oil and gas market.
  • In 2018, Vallen-Systeme GmbH launched AMSY-6 with high-performance USB 3 interface. It has an improved rate of data transfer that boosts the speed of acoustic emission testing.
  • In July 2019, Industrial Inspection & Analysis, Inc. acquired Advanced Technical Services NW, Inc. to broaden its service offerings to achieve the increasing demand for quality and service.
Some of the key players identified across the value chain of the global acoustic emission-based NDT market include MISTRAS, General Electric, KRN Services, Score Atlanta Inc., TÜV Rheinland, Beijing Softland Times Scientific & Technology Co. Ltd., Parker Hannifin, Vallen Systeme GmbH, Cygnus Instruments, Cybernetix, Arudra Engineers Pvt.


About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
at 1 comment:

Global Dairy Derived Flavors Market Expected to Reach ~~ US$ 1.3 Bn by 2029


Persistence Market Research has published a report on the dairy-derived flavors market, which includes the global industry analysis 2014-2018 and opportunity assessment 2019-2029, and projects that the global dairy-derived flavors market is expected to reach ~ US$ 860 Mn by the end of 2019 in terms of value, and is forecasted to reach ~ US$ 1.3 Bn by the end of 2029.

According to the report, increasing adaptation of new and high-end technology is contributing to the growth of the dairy-derived flavors market through 2029. The demand for dairy-derived flavors is increasing continuously and the complex process of extraction increases the turnaround time for dairy-derived flavors. Adaptation of new technology will provide the thrust to the production process of dairy-derived flavors, and help to fulfill the increasing demand for dairy-derived flavors in 2019 and beyond.


Popularity of Dairy-derived Flavors Creating Multiple Opportunities for Market Players

Natural dairy-derived flavors are witnessing exponential demand from mature markets, owing to the side-effects of artificial dairy-derived flavors and the rising health concerns of consumers. According to the PMR report, consumers are getting aware of the ill effects of chemical-based artificial dairy-derived flavors. Mature markets are demanding products with natural ingredients and hence, the manufacturers are forced to use natural dairy-derived flavors in required processed food. On the other hand, the demand for artificial dairy-derived flavors is remaining bullish in developing markets, reveals the PMR research study.

Acquisition Strategy Playing an Important Role in the Market

The demand for dairy-derived flavors continues to rise and the number of new entrants in this market is also increasing continuously. Hence, established players in the market are facing tough competition from the new players. The study shows that more than 55% market share is held by the top 10 players in the market.


The continuously growing demand for dairy-derived flavors and the increasing number of new market players is hampering the market share of the top dairy-derived flavor manufactures. According to the study, the growth opportunity for the top players in the market is to acquire a number of new or smaller businesses. This will help companies to expand their production capacity and market share while creating a strong global footprint in the global dairy-derived flavors market.

For instance, in 2018, International Flavors & Fragrances (IFF) acquired Frutarom, Israel’s leading manufacturer of flavors & ingredients. This acquisition helps the company to bring a new customer base and adjacent product categories to its business. This acquisition is one of the largest acquisitions by any flavor manufacturer.


PMR’s business intelligence also underlines groundbreaking insights into the competitive scenario of the global dairy-derived flavors market along with the highlights of the differential strategies implemented by manufacturers. Key players in the global dairy-derived flavors market continue to invest in growth strategies, which are likely to help them retain or increase their market share in the global dairy-derived flavors market. According to the report, manufacturers are also focusing on acquisition strategies, which will help them to tap the existing business potential and customer base to increase their regional presence across the globe.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
at No comments:

Global Urinary Catheters Market to Witness CAGR of 4% Increase in Value Share During the Forecast Period 2019-2029



Global revenue of urinary catheters reached ~ 1.5 billion in 2018, unveils the new research study by Persistence Market Research (PMR). According to the report, the urinary catheters market is estimated to grow by ~4% YOY in 2019, primarily attributed to ease of use, cost-effective nature, reduced risk of urinary tract infection, and increase in demand as it is an effective solution among the patient population.

Intermittent urinary catheter is gaining a great deal of footing in the market, as intermittent catheterization remains the first and safer method of choice. This urinary catheter does not have many contraindications and permits typical bladder elements. The single-use intermittent urinary catheter is most favoured for intermittent catheterization, as it is advantageous and further brings down the risk of long and transient entanglements.

Get Sample Copy of this report @ https://www.persistencemarketresearch.com/samples/3268 
According to the report, increasing focus on advanced urinary catheters coated with hydrogel, Teflon, silicone, elastomer, etc., is rising owing to increasing concern of regulatory bodies across all regions to reduce the infection during catheterization process.

Demand for Intermittent Urinary Catheters to Create Opportunities for Key Market Players

According to the PMR report, intermittent urinary catheters are likely to dominate the urinary catheters market during the forecasted period, as these catheters are widely used for an effective bladder management strategy for patients with incomplete bladder emptying, due to idiopathic or neurogenic detrusor overactivity. Urinary catheter sales are set to see an uptick, as they are relatively easy to use with just a simple procedure and can be used temporarily after certain types of surgery of the prostate, genitals, or after an abdominal hysterectomy. Indwelling urinary catheters referred as “Foley” is a closed sterile system with catheters and balloon as external devices for collection of urine. The indwelling urinary catheters segment is expected to grow in the forecasted period at a CAGR ~3%, owing to its usage only for short duration, defined as less than 30 days (EAUN recommends no longer than 14 days).

Request Methodology of this report @ https://www.persistencemarketresearch.com/methodology/3268 

Demand for urinary catheters increases with increase in application in various indications namely, urinary incontinence, urinary retention, prostate gland surgery, and spinal cord surgery. Application for urinary catheters in prostate gland surgery will continue to account for greater sales, and it is estimated to shoot up by the end of 2029, due to increasing prevalence of benign prostatic hyperplasia (BPH) and prostate cancer. High application potential is also identified in urinary incontinence, due to its increasing prevalence among women population worldwide.

Investments in Asia Representing Scope for Future Market Growth

A large proportion of the geriatric population aged 65 or above across the globe suffer from urinary disorders, such as urinary retention and incontinence. The elderly population in developed regions such as North America, and Europe is increasingly using urinary catheters. In contrast, urinary catheter usage penetration is relatively low in developing regions such as in Asia and Latin America, which represents scope of further penetration of urinary catheters in these regions.

Additionally, increasing healthcare spending and growing awareness among physicians and patients in developing Asian countries are expected to result in major opportunities for key players in the global market. A research study by Persistence Market Research (PMR) analyzed that the Asian market for urinary catheters is expected to grow by CAGR ~4%. Accounting for ~23% share, the Asian market opens new opportunities for key players to expand their footprint in the region, in the view of improved healthcare facilities and growing healthcare expenditure per capita.


This study underlines key opportunities in the urinary catheters market and finds that the market would exhibit growth at a value CAGR of ~4.0% during the forecast period.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
at No comments:

Thursday, September 12, 2019

Global Flavored Functional Water Market to Witness CAGR of 11.5% Increase in Value Share During the Forecast Period 2013-2019





According to a new market report published by Persistence Market Research “Global Market Study on Flavored and Functional Water: Asia Pacific to Witness Highest Growth by 2019” the global flavored and functional water market was valued at USD 17.2 billion in 2012 and is expected to grow at a CAGR of 11.5% from 2013 to 2019, to reach an estimated value of USD 36.7 billion in 2019.

Increasing obesity rate, rising aging population and changing consumer preferences are the major growth drivers for the global flavored and functional water market. Growing health concerns is restraining the masses from consuming carbonated or artificial flavored drinks and compelling them to opt for flavored and functional water. Flavored and functional water are generally priced similar to carbonated drinks, which reduces the switching costs for the consumers, thus increasing flavored and functional water attractiveness. Major growth challenges for the flavored and functional water industry include threat of substitutes and increasing campaign against packaging bottles. Emerging markets such as countries in Asia, Latin America and the Middle East have witnessed rising urbanization and increasing disposable income, which act as an opportunity for the flavored and functional water. Increasing urbanization has increased the awareness levels of the consumer regarding the products that help in their wellbeing.

Get Sample Copy of this report @  https://www.persistencemarketresearch.com/samples/3027

The increasing income levels have also enabled the consumers to spend on premium products thus providing great opportunity for the market players to focus in these markets. Expansion in the industrial and agriculture sectors in China has resulted in polluted water supplies, which in turn has driven the demand for bottled water, including flavored and functional water segment. The urban population is more conscious about staying fit and their appearance. By linking water to health and beauty regimes, flavored and functional water manufacturers are increasingly positioning their products to take advantage of this.

According to the United Nations, global urban population is expected to increase from 3.4 billion in 2009 to 6.3 billion in 2050. The urban population is more willing to try new products that help in their wellbeing thus offering new opportunity for the market players. The flavored and functional water market is  bifurcated into two segments: Flavored Water and Functional Water. The global flavored and functional water market grew by 7.3% over 2011 to reach USD 17,200.0 million in 2012. Functional water is expected to be the fastest growing segment, registering strong growth over the forecast period.

Request Methodology of this report @ https://www.persistencemarketresearch.com/methodology/3027

The U.S., Germany, France, Italy and Japan were the top markets for flavored and functional water in 2012. Asia Pacific is emerging as a strong market registering double-digit growth in 2012. Some of the major companies operating in Flavored and Functional water are Hint Water, Nestle Water, Herbal Water, PepsiCo, The Coca-Cola Company and Groupe Danone, New York Spring Water, Kraft Foods, Balance Water Company and Sunny Delight Beverage Company.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States

at No comments:

Global Membrane Technology Market to Witness CAGR of 9.1% Increase in Value Share During the Forecast Period 2014-2019




According to a new market report published by Persistence Market Research “Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2019” the global membrane technology market for pharmaceutical, biopharma and life sciences is estimated at USD 7,029.9 million in 2014 and is expected to grow at a CAGR of 9.1% from 2014 to 2019, to reach an estimated value of USD 10,886.0 million in 2019.

The membrane technology market in pharmaceutical, biopharma and life sciences is growing due to increased research and development and production in pharmaceutical, biopharmaceutical and life sciences industries. Moreover, stringent regulations and usage of single-use disposable technique are also playing a major role in growth of the membrane technology market. Presence of various filtration techniques such as ultrafiltration, nanofiltration and microfiltration under membrane technology has increased its acceptance in pharmaceutical, biopharmaceutical and life science industries for separation and purification of components and biomolecules, over conventional techniques.

Get Sample Copy of this report @  https://www.persistencemarketresearch.com/samples/3024

However, the market faces some restraints such as effects of membrane fouling, high operational and investment cost and limitation of membrane materials. As a result, the market is expected to grow at a CAGR of about 9.1% during 2014-2019.

North America is the largest market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. The U.S. is the world’s largest market for pharmaceutical and biopharmaceutical products. According to the European Federation of Pharmaceutical Industries and Associations, North America accounted for about 41% of global pharmaceutical sales in 2012.

Similarly, in Europe, membrane technology is a rapidly growing sector with many associations, organizations and societies actively involved in expansion and implementation of this technology in various industries including pharmaceutical, biopharmaceutical and life sciences.

Request Methodology of this report @ https://www.persistencemarketresearch.com/methodology/3024

However, Asia is the fastest growing region in the membrane technology market due to continuous development in pharmaceutical and biopharmaceutical industries.

GE Healthcare Life Sciences and 3M are some of the leading players in the global membrane technology market in pharmaceutical, biopharma and life sciences. Other major players of the membrane technology market include Pall Corporation, Sartorius, Merck Millipore, Koch Membrane Systems Inc., Novasep, TriSep Corporation, Amazon Filters Ltd. and Advantec MFS.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
at No comments:

Global Clinical Trial Management System Market to Witness CAGR of 14.0% Increase in Value Share During the Forecast Period 2013 to 2019



According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.

Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Globally, the CTMS market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science and clinical research industries. It empowers organizations and research centers to enhance productivity and effectiveness of clinical trials by advancing and managing clinical trials. Integration of CTMS with hospital information system (HIS) provides more accurate and time saving documentation is also driving growth for the CTMS market.

Get Sample Copy of this report @  https://www.persistencemarketresearch.com/samples/3017

Additionally, increasing prevalence of diseases is supporting clinical trials in different regions, and increased clinical research outsourcing is playing a major role in the growth of the CTMS market. Increasing regulatory requirements in many countries has resulted in increased complexity for clinical trial protocols. Presence of various end users such as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has increased the acceptance of CTMS. The global CTMS market was estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to 2019 to reach USD 1,848.5 million in 2019.

North America is a traditional clinical trial region. Due to regulatory and legal considerations and the clinical trial market has shifted from North America to developing countries such as India and China. Clinical trials in the U.S. have been funded and sponsored by National Institute of Health (NIH), other government agencies, academic groups, voluntary health organizations and industry.

In Europe, countries in Central and Eastern Europe provide abundant chance to life science companies for clinical development. Due to governmental support and funding for biomedical sciences, Germany has become a preferred location for clinical trials.

Request Methodology of this report @ https://www.persistencemarketresearch.com/methodology/3017

However, Asia is the fastest growing region in the clinical trial management system market.. Improved industry regulatory laws and patent expiration laws in various countries including Japan, China and India, have led to the expansion of the clinical trials market in Asia. Asia has lower cost of conducting clinical trials compared to Europe or the U.S.

Some of the major players in the CTMS market are Oracle Corporation, Bio-Optronics, MedNet Solutions, PAREXEL International Corporation, Medidata Solutions and BioClinica

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States

at No comments:

Global Microfluidic Devices Market to Witness CAGR of 22.8% Increase in Value Share During the Forecast Period 2013 to 2019





According to a new market report published by Persistence Market Research “Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019” the global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 5,246.4 million in 2019.

Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare.
Miniaturization also reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. In addition, microfluidic proteomic devices are increasingly being used to quantify and identify proteins and to study interactions of different proteins with reagent in array. Different materials such as glass, silicon, polymer metal and ceramics, are used to manufacture microfluidic devices. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.


Error! Filename not specified.

In North America, rising aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and proper insurance coverage are driving the use of microfluidic devices in the market. Usage of microfluidic technology in North America is high compared to other regions of the world due to its early adoption and multiple applications in different industries.
In Europe, the microfluidic device market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. On the other hand, increasing healthcare costs has shifted the focus of healthcare from hospitals to home, which would increase the use of microfluidic devices in the region.

Request Methodology of this report @ https://www.persistencemarketresearch.com/methodology/2995

However, Asia is becoming one of the most attractive markets for medical device companies. The growth for microfluidic devices is much faster than developed countries due to widening health insurance penetration and up-gradation of health care systems. Asia is one of the producers of generic drugs, which require microfluidic devices for toxicity testing of drugs.

Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Bio-Rad Laboratories, Inc, Fluidigm Corporation and Johnson & Johnson are some of the major players of microfluidic device market.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States

at No comments:

Global Pulmonary Fibrosis Treatment Market Expected to be Valued ~US$ 4.4 Bn by 2029




Globally, increasing diagnosis rate for the pulmonary fibrosis is expected to drive the growth of the pulmonary fibrosis treatment market. According to the latest research by the company, the global pulmonary fibrosis treatment market is projected to account for a market value of ~US$ 4.4 Bn by the end of 2029. The report also projects significant growth potential for the pulmonary fibrosis treatment market throughout the forecast period.
Increasing diagnosis rate of the pulmonary fibrosis due to enhanced understanding of the disease is the prime driver of the pulmonary fibrosis treatment market. Although the disease understanding and understanding of the associated symptoms has advanced immensely, misdiagnosis still remains as high as 40% in developed regions, potentially hampering the growth of the pulmonary fibrosis treatment market.

Increasing literature about the pulmonary fibrosis treatment, causes and increasing small and medium sized regional studies by universities, pulmonary fibrosis organizations are assisting to improve the overall awareness about the disease in the general population. The similarities of symptoms of pulmonary fibrosis with other respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, etc. are the major impediments in the precise diagnosis of the disease delaying the pulmonary fibrosis treatment.

Combination Drug Therapies

Corticosteroids, coupled with immunosuppressants and chemotherapeutic agents, were the only treatment available for the pulmonary fibrosis till the drugs such fibrosis Ofev (nintedanib) and Esbriet (pirfenidone) approved for the pulmonary fibrosis treatment in 2014. Both drugs slow disease progression by slowing down the lung tissue scarring. Patients treated with monotherapy of these drugs or combination therapy of these drugs along with corticosteroids or immunosuppressants has given healthcare professionals pulmonary fibrosis treatment options for the effective management of the disease. Various new therapies are being evaluated by pharmaceutical and biopharmaceutical companies for the possible pulmonary fibrosis treatment.

Orphan drug designation reduces drug development cost considerably in turn encouraging pharmaceutical and biopharmaceutical companies to develop drugs for the treatment of rare diseases such as pulmonary fibrosis. Companies that received the orphan drug designation for their products for pulmonary fibrosis treatment benefitted from protocol assistance, marketing authorization, financial incentives, and national incentives provided by the European Commission.

The FDA orphan drug designation programs offer a unique status to biologics and drugs intended to pulmonary fibrosis treatment, diagnose, and prevent diseases in the U.S. The FDA orphan drug designation offers an exclusivity period of seven-year marketing for competition and certain incentives including tax credits, federal grants, and a waiver of PDUFA filing fees. In August 2019, Daewoong Pharmaceutical received orphan drug designation from UFDA for its DWN12088, oral IPF therapy.

The company has segmented the global pulmonary fibrosis treatment market based on the therapy type, indication, distribution channel, and region. In terms of revenue, the monotherapy segment by therapy type is expected to be a prominent segment in pulmonary fibrosis treatment market over the forecast period. By indication, the idiopathic pulmonary fibrosis (IPF) segment of the pulmonary fibrosis treatment market is expected to generate highest revenue during the forecast period due to higher prevalence of the disease type. By distribution channel, the pulmonary fibrosis treatment market is expected to be dominated by the retail sales segment due to higher patient footfall. By region, the North America pulmonary fibrosis treatment market is expected to be a prominent region in the global pulmonary fibrosis treatment market.


The report also profiles some of the key companies operating in the pulmonary fibrosis treatment market such as Genentech, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Alkem Laboratories Ltd., Alniche Life Sciences Pvt Ltd, MHS Pharmaceuticals, Torrent Pharmaceuticals Ltd, Anthem Biopharma Pvt Ltd., Panacea Biotec, Zydus Healthcare Ltd., Fresenius Kabi India Pvt Ltd., Sun Pharmaceutical Industries Ltd and others.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States

at No comments:
Subscribe to: Posts (Atom)

Amplification Sda Market Manufacturing Index Study during forecast period 2019 - 2029

Strand Displacement Amplification (SDA) allows in-vitro nucleic acid amplification using isothermal technique. Nucleic acids being the enc...